Renovaro Biosciences Inc. (RENB)
USD 1.68
(1.2%)
USD 1.68
(1.2%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 121.85 Thousand | 113.49 Thousand | 123.59 Thousand | 391.41 Thousand | 366.26 Thousand | 71.7 Thousand |
| Gross Profit | -121.85 Thousand | -113.49 Thousand | -123.59 Thousand | -391.41 Thousand | -366.26 Thousand | -71.7 Thousand |
| Operating Expenses | 81.63 Million | 19.59 Million | 22.82 Million | 23.4 Million | 11.92 Million | 10.91 Million |
| Selling, General and Administrative Expenses | 24.55 Million | 15.31 Million | 14.32 Million | 7.55 Million | 7.12 Million | 8.42 Million |
| Research and Development Expenses | 2.7 Million | 4.16 Million | 8.37 Million | 15.72 Million | 4.69 Million | 2.49 Million |
| Other Expenses | 54.37 Million | - | - | - | - | - |
| Cost and Expenses | 81.63 Million | 19.59 Million | 22.82 Million | 23.4 Million | 11.92 Million | 10.99 Million |
| Operating Income | -81.63 Million | -38.55 Million | -116.07 Million | -23.4 Million | -11.92 Million | -10.99 Million |
| Interest Expense | 1.01 Million | 706.96 Thousand | 372.84 Thousand | 379.6 Thousand | 104.28 Thousand | 43.00 |
| Income Tax Expense | - | 706.96 Thousand | 34.00 | -125.27 Thousand | 104.28 Thousand | 1.00 |
| Earnings before Tax | -80.65 Million | -39.68 Million | -113.43 Million | -26.84 Million | -11.41 Million | -18.01 Million |
| Net Income | -80.65 Million | -39.68 Million | -113.43 Million | -26.72 Million | -11.41 Million | -18.01 Million |
| Earnings Per Share Basic | -0.84 | -0.71 | -2.16 | -0.57 | -0.25 | -0.48 |
| Earnings Per Share Diluted | -0.84 | -0.71 | -2.16 | -0.57 | -0.25 | -0.48 |
| Weighted Average Shares Outstanding | 96.24 Million | 56.26 Million | 52.52 Million | 47.16 Million | 46.33 Million | 37.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.24 Million | 56.26 Million | 52.52 Million | 47.16 Million | 46.33 Million | 37.55 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -79.51 Million | -19.48 Million | -22.7 Million | -23.27 Million | -11.5 Million | -17.94 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 181.45 Thousand | - | - | - | - | - |
| Cost of Revenue | 90.72 Thousand | 30.3 Thousand | 33.16 Thousand | 27.26 Thousand | 113.49 Thousand | 28 Thousand |
| Gross Profit | 90.72 Thousand | -30.3 Thousand | -33.16 Thousand | -27.26 Thousand | -113.49 Thousand | -28 Thousand |
| Operating Expenses | 17.1 Million | 8.76 Million | 4.27 Million | 8.88 Million | 19.59 Million | 3.97 Million |
| Selling, General and Administrative Expenses | 6.19 Million | 7.65 Million | 3.61 Million | 8.29 Million | - | 2.95 Million |
| Research and Development Expenses | 434.5 Thousand | 1.08 Million | 620.52 Thousand | 566.64 Thousand | - | 994.72 Thousand |
| Other Expenses | 10.47 Million | 42.64 Million | - | - | - | - |
| Cost and Expenses | 17.1 Million | 8.76 Million | 4.27 Million | 8.88 Million | 19.59 Million | 3.97 Million |
| Operating Income | -17.1 Million | -17.19 Million | -4.27 Million | -8.88 Million | -38.55 Million | -22.93 Million |
| Interest Expense | -1.78 Million | 320.07 Thousand | 274.98 Thousand | 179.27 Thousand | 706.96 Thousand | 262.26 Thousand |
| Income Tax Expense | -515.28 Thousand | 320.07 Thousand | 15.93 Thousand | 179.27 Thousand | 706.96 Thousand | 262.26 Thousand |
| Earnings before Tax | -15.73 Million | -17.02 Million | -4.52 Million | -9.17 Million | -39.68 Million | -23.19 Million |
| Net Income | -15.73 Million | -17.02 Million | -4.52 Million | -9.17 Million | -39.68 Million | -23.19 Million |
| Earnings Per Share Basic | -0.15 | -0.16 | -0.07 | -0.14 | - | -0.36 |
| Earnings Per Share Diluted | -0.15 | -0.16 | -0.07 | -0.14 | - | -0.36 |
| Weighted Average Shares Outstanding | 101.86 Million | 107.48 Million | 65.85 Million | 64.48 Million | 56.26 Million | 63.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.86 Million | 107.48 Million | 65.85 Million | 64.48 Million | 56.26 Million | 63.69 Million |
| Gross Margin | 0.50 | - | - | - | - | - |
| EBIT Margin | -36.56 | - | - | - | - | - |
| Profit Margin | -86.70 | - | - | - | - | - |
| EBITDA | -6.63 Million | -8.73 Million | -4.22 Million | -8.84 Million | - | -3.94 Million |
| Earnings Before Tax Margin | -94.26 | - | - | - | - | - |
ACLLF
003690
EZPW
GBX
6743
MRF